Nu Skin CEO granted 249,958 Class A shares

Nu Skin Enterprises President and CEO Ryan S. Napierski reported performance-based equity awards in Class A common stock.

Rhea-AI Filing Summary

Nu Skin Enterprises President and CEO Ryan S. Napierski reported performance-based equity awards in Class A common stock. On February 10, 2026, he acquired 42,970 shares and 206,988 shares at a stated price of $0.00 per share through grants classified as awards or other acquisitions.

The Form 4 shows his directly held Class A common stock rising to 686,403 shares after the first transaction and 893,391 shares after the second. Footnotes explain these awards relate to restricted stock units granted in February 2024 and February 2025, which became eligible for vesting once Nu Skin met specified performance criteria on February 10, 2026.

Insider Trade Summary

Grant/Award: 249,958 shares

Grant/Award 2 txns

Insider NAPIERSKI RYAN S

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	42,970	$0.00	$0.00
Grant/Award	Class A Common Stock	206,988	$0.00	$0.00

Holdings After Transaction: Class A Common Stock — 893,391 shares (Direct)

Footnotes (2)

1. F1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
2. F2. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Nu Skin (NUS) report for Ryan S. Napierski?

Nu Skin reported that President and CEO Ryan S. Napierski acquired Class A common stock through equity awards on February 10, 2026. Two separate award transactions increased his directly held shares as performance-based restricted stock units became eligible for vesting after Nu Skin met required criteria.

How many Nu Skin (NUS) shares did the CEO acquire in this Form 4?

Ryan S. Napierski acquired 42,970 Class A shares in one award and 206,988 Class A shares in another, both on February 10, 2026. These were reported as grants or other acquisitions at a stated price of $0.00 per share under the company’s equity compensation structure.

What is Ryan S. Napierski’s Nu Skin (NUS) share ownership after these transactions?

After the first equity award, Napierski directly held 686,403 Class A shares, and after the second, 893,391 shares. The filing shows only direct ownership, with no indirect ownership noted, reflecting the impact of the reported performance-based equity awards on his holdings.

What triggered the Nu Skin (NUS) performance-based stock awards reported in this Form 4?

The awards were triggered when Nu Skin satisfied specified performance criteria on February 10, 2026. These criteria applied to restricted stock units originally granted on February 27, 2024, and February 26, 2025, causing the reported share amounts to become eligible for vesting at that time.

Is the Nu Skin (NUS) CEO’s Form 4 transaction a purchase or an award?

The Form 4 classifies both entries as grants, awards, or other acquisitions, not open-market purchases. The transactions reflect restricted stock units converting into eligible shares after Nu Skin met performance conditions, with a reported transaction price of $0.00 per share for each award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 06:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NAPIERSKI RYAN S

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/10/2026		A		42,970(1)	A	$0.00	686,403	D
Class A Common Stock	02/10/2026		A		206,988(2)	A	$0.00	893,391	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

2. On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

	/s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.